SCHEMBL20053374

SCHEMBL20053374

c1ccc(-c2c3ccccc3c(-c3ccc4c(c3)sc3c5cccc(-c6ccc(-c7c8ccccc8c(-c8cccc(-c9ccc%10sc%11cc%12ccccc%12cc%11c%10c9)c8)c8ccccc78)cc6)c5ccc43)c3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.38
F9 P00740 1/20 0.35
ESR1 P03372 6/20 0.34
ESR2 Q92731 5/20 0.34
LIMK1 P53667 2/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
PIM3 Q86V86 2/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
HSD17B1 P14061 1/20 0.32
HSD17B2 P37059 1/20 0.32
MCL1 Q07820 1/20 0.31
S1PR4 O95977 1/20 0.31
S1PR5 Q9H228 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23060163 0.92 CYP1A1 (0.39) ALOX5F9ESR1ESR2LIMK1
SCHEMBL22858125 0.91 CYP1A1 (0.41) ALOX5F9ESR1ESR2LIMK1
SCHEMBL19082226 0.90 ESR1 (0.39) ALOX5F9ESR1ESR2LIMK1
SCHEMBL24923182 0.89 CYP1A1 (0.39) ALOX5F9ESR1ESR2LIMK1
SCHEMBL17247090 0.88 CA12 (0.41) F9ESR1ESR2CA12CA1
SCHEMBL17247130 0.88 CA12 (0.41) F9ESR1ESR2CA12CA1
SCHEMBL19082222 0.88 ESR1 (0.40) ALOX5ESR1ESR2LIMK1CYP1A1
SCHEMBL17944974 0.88 ESR1 (0.42) ALOX5F9ESR1ESR2LIMK1
SCHEMBL20375102 0.88 CA12 (0.40) F9ESR1ESR2CA12CA1
SCHEMBL19082243 0.87 ESR1 (0.36) ALOX5F9ESR1ESR2LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11839153-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO.,LTD. (JP) 2023-12-05 US disclosed
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD (JP) 2023-05-04 US disclosed
US-11618722-B2 Compound, composition, organic electroluminescent element, and electronic appliance IDEMITSU KOSAN CO., LTD. (JP) 2023-04-04 US disclosed
US-20210062078-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-03-04 US disclosed
US-20200266361-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-08-20 US disclosed
US-10680181-B2 Organic electroluminescence device and novel compound IDEMITSU KOSAN CO., LTD. (JP) 2020-06-09 US disclosed
US-20190355914-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2019-11-21 US disclosed
US-9947879-B2 Anthracene derivative and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11839153-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device RER1, RPS19, RPL19 ALOX5 2228/4885F9 169/4885ESR1 5/4885
US-10680181-B2 Organic electroluminescence device and novel compound PIEZO1, TMEM109, OXA1L ALOX5 4031/4885F9 2585/4885ESR1 208/4885
US-11618722-B2 Compound, composition, organic electroluminescent element, and electronic appliance FGF23, SUZ12, RPL24 ALOX5 3406/4885F9 318/4885ESR1 224/4885
US-20190355914-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND PIEZO1, TMEM109, OXA1L ALOX5 4031/4885F9 2585/4885ESR1 208/4885
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND DDT, DDC, ODC1 ALOX5 2721/4885F9 2061/4885ESR1 105/4885
US-20200266361-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE RER1, RPS19, RPL19 ALOX5 2228/4885F9 169/4885ESR1 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.